Health Status and Treatment Outcome of Tuberculosis with Diabetes Mellitus Cases, Rajkot City, Gujarat - A Longitudinal Study
- PMID: 37082395
- PMCID: PMC10112767
- DOI: 10.4103/ijcm.ijcm_171_22
Health Status and Treatment Outcome of Tuberculosis with Diabetes Mellitus Cases, Rajkot City, Gujarat - A Longitudinal Study
Abstract
Background: India, with the highest number of tuberculosis (TB) cases in the world, is also facing epidemic growth in diabetes mellitus (DM). TB is curable while DM is a metabolic and incurable disease that if not controlled will affect the health status of a person. This study was conducted to assess the health status and treatment outcome of TB with DM cases.
Materials and methods: We selected a total of 64 newly registered pulmonary TB (PTB) with DM cases from five tuberculosis units (TUs) in Rajkot city from October 2019 to December 2020. At the end of treatment, 64 cases were analyzed for treatment outcome and 56 cases (5 deaths; 3 lost to follow-up) were followed up to observe progression in health status. The information was collected in pretested proforma by interview.
Results: There was a significant improvement in TB symptoms (cough, weight loss, weakness, anorexia, evening rise of temperature, dyspnea, chest pain, hemoptysis), DM symptoms (frequent urination, excessive thirst and hunger, tingling and numbness), symptoms of mental health (fatigue, sleep disturbance, negative emotions, socially inactive), and adverse drug reactions (ADRs) on consecutive visits (McNemar's test, P < 0.001) and at the end of treatment (Cochran's Q test, P < 0.001). Improvement of nutritional status was also found statistically significant on consecutive visits (Wilcoxon test, P < 0.001) and at the end of treatment (Friedman's test, P < 0.001). The cure rate was 82.8% and 4.7% of cases had completed treatment.
Conclusion: At the end of treatment, there was a significant improvement in health status and treatment outcome; also good cure rate was reported among cases.
Keywords: Diabetes mellitus; health status; treatment outcome; tuberculosis.
Copyright: © 2022 Indian Journal of Community Medicine.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Evaluation of treatment outcome and adverse drug reaction of directly observed treatment (DOT) plus regimen in multidrug-resistant tuberculosis (MDR-TB) patients at district tuberculosis centre Rajkot.Perspect Clin Res. 2018 Oct-Dec;9(4):165-169. doi: 10.4103/picr.PICR_165_17. Perspect Clin Res. 2018. PMID: 30319946 Free PMC article.
-
Comparative evaluation of INF-γ as an immunological healing marker based on anti-tubercular treatment among diabetic and non-diabetic pulmonary tuberculosis patients.Horm Mol Biol Clin Investig. 2022 Sep 26;44(1):33-37. doi: 10.1515/hmbci-2022-0031. eCollection 2023 Mar 1. Horm Mol Biol Clin Investig. 2022. PMID: 36148507
-
[Tuberculosis in compromised hosts].Kekkaku. 2003 Nov;78(11):717-22. Kekkaku. 2003. PMID: 14672050 Japanese.
-
The epidemiology of tuberculosis-associated hyperglycemia in individuals newly screened for type 2 diabetes mellitus: systematic review and meta-analysis.BMC Infect Dis. 2020 Dec 9;20(1):937. doi: 10.1186/s12879-020-05512-7. BMC Infect Dis. 2020. PMID: 33297969 Free PMC article.
-
Systematic review and meta-analysis: Prevalence of diabetes among patients with tuberculosis in China.Trop Med Int Health. 2021 Dec;26(12):1553-1559. doi: 10.1111/tmi.13686. Epub 2021 Oct 25. Trop Med Int Health. 2021. PMID: 34637179
References
-
- Yorke E, Atiase Y, Akpalu J, Sarfo-Kantanka O, Boima V, Dey ID. The Bidirectional relationship between tuberculosis and diabetes. Tuberc Res Treat. 2017 https://doi.org/10.1155/2017/1702578. - PMC - PubMed
LinkOut - more resources
Full Text Sources